Literature DB >> 12708530

Effects of D-cycloserine on extinction of conditioned freezing.

Lana Ledgerwood1, Rick Richardson, Jacquelyn Cranney.   

Abstract

The present study tested the prediction that D-cycloserine (DCS), a partial N-methyl-D-aspartate agonist, would facilitate extinction of conditioned freezing in male Sprague-Dawley rats. Rats received 5 light-shock pairings (conditioning). The following day, rats received 6 light-alone presentations (extinction training). Twenty-four hours later, rats received 1 light-alone presentation (test). Subcutaneous DCS injection before or after extinction training significantly enhanced extinction, and the dose-response curve for this effect was linear. Increasing the delay of DCS administration after extinction training led to a linear decrease in the facilitatory effect. The effect of systemic administration was replicated by intra-basolateral amygdala infusion. These results suggest that DCS facilitates extinction of conditioned freezing by acting on consolidation processes partly mediated by the basolateral amygdala.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12708530     DOI: 10.1037/0735-7044.117.2.341

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  152 in total

Review 1.  Pharmacological enhancement of drug cue extinction learning: translational challenges.

Authors:  K M Kantak; B Á Nic Dhonnchadha
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  Neural and cellular mechanisms of fear and extinction memory formation.

Authors:  Caitlin A Orsini; Stephen Maren
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

3.  Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice.

Authors:  Gongliang Zhang; Herborg N Ásgeirsdóttir; Sarah J Cohen; Alcira H Munchow; Mercy P Barrera; Robert W Stackman
Journal:  Neuropharmacology       Date:  2012-06-18       Impact factor: 5.250

Review 4.  Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.

Authors:  Michael W Otto; M Alexandra Kredlow; Jasper A J Smits; Stefan G Hofmann; David F Tolin; Rianne A de Kleine; Agnes van Minnen; A Eden Evins; Mark H Pollack
Journal:  Biol Psychiatry       Date:  2015-09-25       Impact factor: 13.382

Review 5.  Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning.

Authors:  Travis P Todd; Drina Vurbic; Mark E Bouton
Journal:  Neurobiol Learn Mem       Date:  2013-08-30       Impact factor: 2.877

6.  Extinction training in conjunction with a partial agonist of the glycine site on the NMDA receptor erases memory trace.

Authors:  Sheng-Chun Mao; Ya-Hsin Hsiao; Po-Wu Gean
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

7.  Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice.

Authors:  Ravikumar Ponnusamy; Helen A Nissim; Mark Barad
Journal:  Learn Mem       Date:  2005 Jul-Aug       Impact factor: 2.460

8.  Augmentation of exposure therapy with post-session administration of D-cycloserine.

Authors:  Candyce D Tart; Pamela R Handelsman; Lindsey B Deboer; David Rosenfield; Mark H Pollack; Stefan G Hofmann; Mark B Powers; Michael W Otto; Jasper A J Smits
Journal:  J Psychiatr Res       Date:  2012-10-23       Impact factor: 4.791

9.  D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.

Authors:  JoAnn Difede; Judith Cukor; Katarzyna Wyka; Megan Olden; Hunter Hoffman; Francis S Lee; Margaret Altemus
Journal:  Neuropsychopharmacology       Date:  2013-11-12       Impact factor: 7.853

Review 10.  Neural mechanisms of pain and alcohol dependence.

Authors:  A Vania Apkarian; Volker Neugebauer; George Koob; Scott Edwards; Jon D Levine; Luiz Ferrari; Mark Egli; Soundar Regunathan
Journal:  Pharmacol Biochem Behav       Date:  2013-10-02       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.